Matches in Wikidata for { <http://www.wikidata.org/entity/Q67126884> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q67126884 description "clinical trial" @default.
- Q67126884 description "ensayu clínicu" @default.
- Q67126884 description "klinisch onderzoek" @default.
- Q67126884 description "клінічне випробування" @default.
- Q67126884 name "Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery" @default.
- Q67126884 name "Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery" @default.
- Q67126884 type Item @default.
- Q67126884 label "Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery" @default.
- Q67126884 label "Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery" @default.
- Q67126884 prefLabel "Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery" @default.
- Q67126884 prefLabel "Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery" @default.
- Q67126884 P1050 Q67126884-F542AAFA-6BEE-4EDC-BAC0-9B573DF86556 @default.
- Q67126884 P1132 Q67126884-DE50F346-EA59-43B5-A6C5-5560235EF910 @default.
- Q67126884 P1476 Q67126884-F20D59A6-68D7-4123-9F53-2FC65EB4B475 @default.
- Q67126884 P17 Q67126884-F5763BED-8D80-4F39-87F2-E81FC99F096E @default.
- Q67126884 P2899 Q67126884-6AE7C6CC-797C-4711-86FC-176CE2546BC4 @default.
- Q67126884 P3098 Q67126884-8DAE0780-8CBA-420D-8BCF-1EFBAFF02653 @default.
- Q67126884 P31 Q67126884-508BBF58-4EFC-4A8C-A2CE-AC55883B9ACB @default.
- Q67126884 P4844 Q67126884-19697265-C703-4E51-A375-146972541AAF @default.
- Q67126884 P4844 Q67126884-D7841530-73A4-4F62-85E0-B77B90A6251A @default.
- Q67126884 P580 Q67126884-20604860-31EE-4173-8053-63A0D9BC0A95 @default.
- Q67126884 P582 Q67126884-A9470174-7C71-441D-8B43-26327A9F4145 @default.
- Q67126884 P6099 Q67126884-12EB20A9-174D-4D06-BC6F-6128D58EE17F @default.
- Q67126884 P6099 Q67126884-1B513A92-0ECB-4839-9E13-E3BB5EE5AC1C @default.
- Q67126884 P8363 Q67126884-8C3C9EC8-991C-4E0E-96A9-9E51E6980F37 @default.
- Q67126884 P859 Q67126884-671E091E-B6BA-45AD-96FC-184AF1ACA227 @default.
- Q67126884 P1050 Q33525 @default.
- Q67126884 P1132 "+49" @default.
- Q67126884 P1476 "A Single Arm Phase I/II Study of MK-3475 Combined With Vorinostat for Recurrent Unresectable and/or Metastatic Squamous Cell Head and Neck Cancer and Recurrent Unresectable and/or Metastatic Salivary Gland Malignancies" @default.
- Q67126884 P17 Q30 @default.
- Q67126884 P2899 "+18" @default.
- Q67126884 P3098 "NCT02538510" @default.
- Q67126884 P31 Q30612 @default.
- Q67126884 P4844 Q13896859 @default.
- Q67126884 P4844 Q905901 @default.
- Q67126884 P580 "2015-10-08T00:00:00Z" @default.
- Q67126884 P582 "2019-09-25T00:00:00Z" @default.
- Q67126884 P6099 Q42824440 @default.
- Q67126884 P6099 Q5452194 @default.
- Q67126884 P8363 Q78089383 @default.
- Q67126884 P859 Q219563 @default.